Vaccination is moving faster than the government’s AstraZeneca strategy. 65% of the population between 60 and 69 years of age, the target audience for the serum, has already received at least half a guideline. And although there are still two million people to name, it is expected to have finished by the end of May with the first doses in this strip. Health also foresees during this month to have the results of your CombiVacs studio, with which you will decide whether to administer second doses of AstraZeneca to those under 55 who received it before April or will give them Pfizer. Assuming that these vaccines are still in the air, Spain would have two million unassigned of the 12 acquired from the Anglo-Swedish company.
US Supports Suspending Patents for COVID Vaccines